Kailera Therapeutics KLRA Institutional Ownership

NASDAQ KLRA

$12.65 -0.20 (-1.56%)

As of: Oct 26, 2026 · 3:22 PM EDT

Institutions by Trading Activity

100 Institutions

Increased 100 100.0%

Unchanged 0 0.0%

Reduced 0 0.0%

Ownership Statistics

13F · as of 30 Jun, 2026

Institutional Ownership

89.50%

Shares Held by Institutions

116.01Mn

of 129.62Mn outstanding

■0.00% QoQ

Shares Outstanding

129.62Mn

13.61Mn held outside 13F filers

Institutional Investors

100

filed 13F for Jun 2026

Net Shares Added (QoQ)

+116.01Mn

accumulated since last quarter

Value of Holdings

$1.49Bn

reported market value

Shares Owned by Institutions

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Institutions

Accumulated Distributed

Latest quarter —

Net over range —

Accumulating quarters —

Ownership Summary

Updated Oct 10, 2026

Kailera Therapeutics, Inc. (NASDAQ:KLRA) counted 100 institutional investors among its 13F-reported shareholders for the quarter ended June 30, 2026.

These investors owned 89.50% of Kailera Therapeutics' outstanding stock in Q2 2026.
In total, institutional investors held 116.01Mn shares of Kailera Therapeutics at the end of Q2 2026.
As of June 30, 2026, Bain Capital Investors LLC held the largest stake in Kailera Therapeutics with 26.26Mn shares, or 20.26% of shares outstanding.
Kailera Therapeutics' 10 largest institutional shareholders as of Q2 2026 were Bain Capital Investors LLC (26.26Mn shares), Bain Capital Life Sciences Investors, LLC (22.58Mn shares), RTW Investments, LP (10.78Mn shares), Canada Pension Plan Investment Board (7.3Mn shares), Atlas Venture Life Science Advisors, LLC (5.17Mn shares), FMR LLC (3.97Mn shares), BlackRock, Inc. (3.93Mn shares), T. Rowe Price Associates Inc (3.53Mn shares), Citadel Advisors LLC (3.24Mn shares) and Adage Capital Partners GP, L.L.C. (3.21Mn shares), per Business Quant data.

Form 13F Holdings

100 Institutional Holders

Report period 30 Jun, 2026

Total shares held 116.01Mn

Of outstanding 89.50%

#	Institution	CIK	Shares Held	% of Outstanding	Change (QoQ)	Change (%)	Value (USD)
1	BAIN CAPITAL INVESTORS LLC	0001040508	26,255,581	20.26%	▲26,255,581	0.00%	$578.41Mn
2	Bain Capital Life Sciences Investors, LLC	0001703031	22,583,268	17.42%	▲22,583,268	0.00%	$497.51Mn
3	RTW INVESTMENTS, LP	0001493215	10,776,820	8.31%	▲10,776,820	0.00%	$237.41Mn
4	CANADA PENSION PLAN INVESTMENT BOARD	0001283718	7,304,688	5.64%	▲7,304,688	0.00%	$160.92Mn
5	Atlas Venture Life Science Advisors, LLC	0001917529	5,171,282	3.99%	▲5,171,282	0.00%	$113.92Mn
6	FMR LLC	0000315066	3,970,865	3.06%	▲3,970,865	0.00%	$87.48Mn
7	BlackRock, Inc.	0002012383	3,928,604	3.03%	▲3,928,604	0.00%	$86.55Mn
8	PRICE T ROWE ASSOCIATES INC /MD/	0000080255	3,534,410	2.73%	▲3,534,410	0.00%	$77.86K
9	CITADEL ADVISORS LLC	0001423053	3,240,787	2.50%	▲3,240,787	0.00%	$71.39Mn
10	ADAGE CAPITAL PARTNERS GP, L.L.C.	0001165408	3,208,286	2.48%	▲3,208,286	0.00%	$70.68Mn
11	WELLINGTON MANAGEMENT GROUP LLP	0000902219	2,919,110	2.25%	▲2,919,110	0.00%	$64.31Mn
12	Royalty Pharma Sub-Manager, LLC	0002081668	2,455,357	1.89%	▲2,455,357	0.00%	$54.09Mn
13	Siren, L.L.C.	0002005245	2,214,286	1.71%	▲2,214,286	0.00%	$48.78Mn
14	VANGUARD CAPITAL MANAGEMENT LLC	0002100119	1,693,958	1.31%	▲1,693,958	0.00%	$37.32Mn
15	VANGUARD PORTFOLIO MANAGEMENT LLC	0002100121	1,652,507	1.27%	▲1,652,507	0.00%	$36.40Mn
16	GEODE CAPITAL MANAGEMENT, LLC	0001214717	1,133,115	0.87%	▲1,133,115	0.00%	$24.97Mn
17	FARALLON CAPITAL MANAGEMENT, L.L.C.	0000909661	1,100,000	0.85%	▲1,100,000	0.00%	$24.23Mn
17	Frazier Life Sciences Management, L.P.	0001892134	1,100,000	0.85%	▲1,100,000	0.00%	$24.23Mn
18	Trails Edge Capital Partners, LP	0002077247	984,786	0.76%	▲984,786	0.00%	$21.69Mn
19	UBS Group AG	0001610520	972,683	0.75%	▲972,683	0.00%	$21.43Mn

Showing 1 to 20 of 100 holders